Astria Therapeutics Inc. logo

Astria Therapeutics Inc.

ATXS | NASDAQ
Chart Builder DCF Calculator
$12.58
$0 (0.00%)
At close: Jan 23, 2026, 4:00 PM ET

Market Data

Market Cap
$718.13M
Enterprise Value
$494.87M
Beta
0.02
Average Volume
1.07M
Shares Outstanding (Diluted)
58.01M
Shares Change YoY
2.69%
Institutional Ownership
99.27%
Exchange
NASDAQ
ISIN
US04635X1028

Price Performance

Price Change 1M
-4.3%
Price Change 3M
1.5%
Price Change 6M
82.6%
Price Change YTD
-4.3%
Price Change 1Y
60.0%
Price Change 3Y
-11.8%
Price Change 5Y
-36.5%
1M CAGR (ann.)
-2.9%
1Y CAGR (ann.)
67.7%
5Y CAGR (ann.)
-4.3%
All-Time CAGR
-32.3%

Valuation

PE Ratio
-5.85
Forward PE
N/A
PEG Ratio
0.90
Forward PEG
1.01
PS Ratio
1,017.18
Forward PS
76.00
PB Ratio
3.08
P/FCF Ratio
-5.97
P/Adj. FCF Ratio
-5.44
P/OCF Ratio
-7.15
EV/Sales
700.94
EV/EBIT
-3.69
EV/EBITDA
-3.69
EV/FCF
-4.11
Earnings Yield
-17.1%
FCF Yield
-16.8%
Adj. FCF Yield
-18.4%

Financial Health

Net Cash
$227.72M
Total Debt
$4.46M
Cash & Short-Term Investments
$227.72M
Total Assets
$271.87M
Current Ratio
10.78
Quick Ratio
10.78
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.03
Debt / FCF
-0.04
OCF / Debt
-26.85
Interest Coverage
0.00
Altman Z-Score
6.57
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-19335.7%
EBITDA Margin
-13938.2%
Net Profit Margin
-13938.2%
FCF Margin
-17042.9%
Adj. FCF Margin
-18685.0%
SBC / Revenue
1770.3%
SBC Impact (per share)
-9.6%

Returns

Return on Assets
-36.2%
Return on Equity
-37.7%
Return on Invested Capital
-42.8%
Return on Capital Employed
-43.0%
Return on Tangible Assets
-36.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
100.0%
Revenue CAGR 10Y
16.9%
EPS CAGR 3Y
-0.2%
EPS CAGR 5Y
81.0%
EPS CAGR 10Y
34.8%
FCF CAGR 3Y
-40.6%
FCF CAGR 5Y
-34.6%
FCF CAGR 10Y
-17.7%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
8
EPS Growth Next 3Y
67.3%
Revenue Growth Next 3Y
730.7%
Earnings Date
Nov 11, 2025
EPS Estimate (next Q)
-$0.41
EPS Growth Est (next Q)
-2.4%
Revenue Est (next Q)
$10.67M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$19.40
Price Target Upside
54.2%

Cash Flow

Operating Cash Flow
$-119.73M
Free Cash Flow
$-120.32M
Adj. Free Cash Flow
$-131.92M
FCF Per Share
-$1.78
OCF Per Share
-$1.76
OCF/S Ratio
-14500.1%

Income Statement

Revenue
$706K
Gross Profit
$706K
Operating Income
$-136.51M
EBITDA
$-134.05M
Net Income
$-124.03M
EPS (Diluted)
-$2.15
Revenue / Employee
$9.05K
Profit / Employee
$-1.59M
Employees
78

© 2026 bestshares.com. All rights reserved.